nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ABCG2—Omeprazole—Barrett's esophagus	0.318	0.428	CbGbCtD
Vemurafenib—CYP1A2—Omeprazole—Barrett's esophagus	0.131	0.177	CbGbCtD
Vemurafenib—CYP3A4—Esomeprazole—Barrett's esophagus	0.117	0.157	CbGbCtD
Vemurafenib—CYP2D6—Omeprazole—Barrett's esophagus	0.108	0.146	CbGbCtD
Vemurafenib—CYP3A4—Omeprazole—Barrett's esophagus	0.0687	0.0925	CbGbCtD
Vemurafenib—ORM1—bile—Barrett's esophagus	0.0168	0.581	CbGeAlD
Vemurafenib—Polyp—Omeprazole—Barrett's esophagus	0.00597	0.0338	CcSEcCtD
Vemurafenib—Polyp—Esomeprazole—Barrett's esophagus	0.00597	0.0338	CcSEcCtD
Vemurafenib—Cyst—Esomeprazole—Barrett's esophagus	0.00543	0.0308	CcSEcCtD
Vemurafenib—Cyst—Omeprazole—Barrett's esophagus	0.00543	0.0308	CcSEcCtD
Vemurafenib—Etoricoxib—PTGS2—Barrett's esophagus	0.00462	1	CrCbGaD
Vemurafenib—Rigors—Omeprazole—Barrett's esophagus	0.00445	0.0252	CcSEcCtD
Vemurafenib—Rigors—Esomeprazole—Barrett's esophagus	0.00445	0.0252	CcSEcCtD
Vemurafenib—RAF1—epithelium—Barrett's esophagus	0.00348	0.121	CbGeAlD
Vemurafenib—RAF1—smooth muscle tissue—Barrett's esophagus	0.00336	0.117	CbGeAlD
Vemurafenib—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.0033	0.0187	CcSEcCtD
Vemurafenib—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.0033	0.0187	CcSEcCtD
Vemurafenib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00328	0.0186	CcSEcCtD
Vemurafenib—Neoplasm—Omeprazole—Barrett's esophagus	0.00328	0.0186	CcSEcCtD
Vemurafenib—Photosensitivity—Esomeprazole—Barrett's esophagus	0.003	0.017	CcSEcCtD
Vemurafenib—Photosensitivity—Omeprazole—Barrett's esophagus	0.003	0.017	CcSEcCtD
Vemurafenib—Arthritis—Esomeprazole—Barrett's esophagus	0.00271	0.0154	CcSEcCtD
Vemurafenib—Arthritis—Omeprazole—Barrett's esophagus	0.00271	0.0154	CcSEcCtD
Vemurafenib—RAF1—digestive system—Barrett's esophagus	0.00265	0.092	CbGeAlD
Vemurafenib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00263	0.0149	CcSEcCtD
Vemurafenib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00263	0.0149	CcSEcCtD
Vemurafenib—Dry skin—Esomeprazole—Barrett's esophagus	0.00242	0.0137	CcSEcCtD
Vemurafenib—Dry skin—Omeprazole—Barrett's esophagus	0.00242	0.0137	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00237	0.0135	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00237	0.0135	CcSEcCtD
Vemurafenib—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00236	0.0493	CbGpPWpGaD
Vemurafenib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00208	0.0118	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00208	0.0118	CcSEcCtD
Vemurafenib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00206	0.0117	CcSEcCtD
Vemurafenib—Weight decreased—Omeprazole—Barrett's esophagus	0.00206	0.0117	CcSEcCtD
Vemurafenib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00203	0.0115	CcSEcCtD
Vemurafenib—Infestation—Esomeprazole—Barrett's esophagus	0.00203	0.0115	CcSEcCtD
Vemurafenib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00203	0.0115	CcSEcCtD
Vemurafenib—Infestation—Omeprazole—Barrett's esophagus	0.00203	0.0115	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00201	0.0114	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00201	0.0114	CcSEcCtD
Vemurafenib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.0018	0.0102	CcSEcCtD
Vemurafenib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.0018	0.0102	CcSEcCtD
Vemurafenib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00179	0.0102	CcSEcCtD
Vemurafenib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00179	0.0102	CcSEcCtD
Vemurafenib—ABCC1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00175	0.0366	CbGpPWpGaD
Vemurafenib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00172	0.00977	CcSEcCtD
Vemurafenib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00172	0.00977	CcSEcCtD
Vemurafenib—Eye disorder—Esomeprazole—Barrett's esophagus	0.0017	0.00966	CcSEcCtD
Vemurafenib—Eye disorder—Omeprazole—Barrett's esophagus	0.0017	0.00966	CcSEcCtD
Vemurafenib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00164	0.00932	CcSEcCtD
Vemurafenib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00164	0.00932	CcSEcCtD
Vemurafenib—Chills—Omeprazole—Barrett's esophagus	0.00164	0.00928	CcSEcCtD
Vemurafenib—Chills—Esomeprazole—Barrett's esophagus	0.00164	0.00928	CcSEcCtD
Vemurafenib—Alopecia—Esomeprazole—Barrett's esophagus	0.00161	0.00914	CcSEcCtD
Vemurafenib—Alopecia—Omeprazole—Barrett's esophagus	0.00161	0.00914	CcSEcCtD
Vemurafenib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00159	0.009	CcSEcCtD
Vemurafenib—Malnutrition—Omeprazole—Barrett's esophagus	0.00159	0.009	CcSEcCtD
Vemurafenib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00155	0.00881	CcSEcCtD
Vemurafenib—Dysgeusia—Omeprazole—Barrett's esophagus	0.00155	0.00881	CcSEcCtD
Vemurafenib—Back pain—Esomeprazole—Barrett's esophagus	0.00153	0.0087	CcSEcCtD
Vemurafenib—Back pain—Omeprazole—Barrett's esophagus	0.00153	0.0087	CcSEcCtD
Vemurafenib—Cough—Esomeprazole—Barrett's esophagus	0.00138	0.00785	CcSEcCtD
Vemurafenib—Cough—Omeprazole—Barrett's esophagus	0.00138	0.00785	CcSEcCtD
Vemurafenib—Myalgia—Esomeprazole—Barrett's esophagus	0.00135	0.00766	CcSEcCtD
Vemurafenib—Arthralgia—Omeprazole—Barrett's esophagus	0.00135	0.00766	CcSEcCtD
Vemurafenib—Myalgia—Omeprazole—Barrett's esophagus	0.00135	0.00766	CcSEcCtD
Vemurafenib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00135	0.00766	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00134	0.00761	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00134	0.00761	CcSEcCtD
Vemurafenib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00129	0.00734	CcSEcCtD
Vemurafenib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00129	0.00734	CcSEcCtD
Vemurafenib—Infection—Esomeprazole—Barrett's esophagus	0.00129	0.0073	CcSEcCtD
Vemurafenib—Infection—Omeprazole—Barrett's esophagus	0.00129	0.0073	CcSEcCtD
Vemurafenib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00127	0.0072	CcSEcCtD
Vemurafenib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00127	0.0072	CcSEcCtD
Vemurafenib—Skin disorder—Esomeprazole—Barrett's esophagus	0.00126	0.00713	CcSEcCtD
Vemurafenib—Skin disorder—Omeprazole—Barrett's esophagus	0.00126	0.00713	CcSEcCtD
Vemurafenib—ABCC1—Irinotecan Pathway—APC—Barrett's esophagus	0.00125	0.0262	CbGpPWpGaD
Vemurafenib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00118	0.00669	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00118	0.00669	CcSEcCtD
Vemurafenib—Decreased appetite—Omeprazole—Barrett's esophagus	0.00113	0.00638	CcSEcCtD
Vemurafenib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00113	0.00638	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00112	0.00634	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00112	0.00634	CcSEcCtD
Vemurafenib—Fatigue—Omeprazole—Barrett's esophagus	0.00112	0.00633	CcSEcCtD
Vemurafenib—Fatigue—Esomeprazole—Barrett's esophagus	0.00112	0.00633	CcSEcCtD
Vemurafenib—Constipation—Omeprazole—Barrett's esophagus	0.00111	0.00628	CcSEcCtD
Vemurafenib—Constipation—Esomeprazole—Barrett's esophagus	0.00111	0.00628	CcSEcCtD
Vemurafenib—ABCG2—Irinotecan Pathway—APC—Barrett's esophagus	0.0011	0.0231	CbGpPWpGaD
Vemurafenib—CYP1A2—digestive system—Barrett's esophagus	0.00106	0.0366	CbGeAlD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00102	0.0214	CbGpPWpGaD
Vemurafenib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00102	0.00581	CcSEcCtD
Vemurafenib—Body temperature increased—Omeprazole—Barrett's esophagus	0.00102	0.00581	CcSEcCtD
Vemurafenib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000954	0.00541	CcSEcCtD
Vemurafenib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000954	0.00541	CcSEcCtD
Vemurafenib—Asthenia—Omeprazole—Barrett's esophagus	0.000929	0.00527	CcSEcCtD
Vemurafenib—Asthenia—Esomeprazole—Barrett's esophagus	0.000929	0.00527	CcSEcCtD
Vemurafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.000926	0.0194	CbGpPWpGaD
Vemurafenib—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000923	0.0193	CbGpPWpGaD
Vemurafenib—Pruritus—Esomeprazole—Barrett's esophagus	0.000916	0.0052	CcSEcCtD
Vemurafenib—Pruritus—Omeprazole—Barrett's esophagus	0.000916	0.0052	CcSEcCtD
Vemurafenib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000886	0.00503	CcSEcCtD
Vemurafenib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000886	0.00503	CcSEcCtD
Vemurafenib—Dizziness—Omeprazole—Barrett's esophagus	0.000856	0.00486	CcSEcCtD
Vemurafenib—Dizziness—Esomeprazole—Barrett's esophagus	0.000856	0.00486	CcSEcCtD
Vemurafenib—RAF1—Signaling of Hepatocyte Growth Factor Receptor—HGF—Barrett's esophagus	0.000838	0.0175	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.00083	0.0173	CbGpPWpGaD
Vemurafenib—Vomiting—Esomeprazole—Barrett's esophagus	0.000823	0.00467	CcSEcCtD
Vemurafenib—Vomiting—Omeprazole—Barrett's esophagus	0.000823	0.00467	CcSEcCtD
Vemurafenib—Rash—Esomeprazole—Barrett's esophagus	0.000816	0.00463	CcSEcCtD
Vemurafenib—Rash—Omeprazole—Barrett's esophagus	0.000816	0.00463	CcSEcCtD
Vemurafenib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000816	0.00463	CcSEcCtD
Vemurafenib—Dermatitis—Omeprazole—Barrett's esophagus	0.000816	0.00463	CcSEcCtD
Vemurafenib—Headache—Esomeprazole—Barrett's esophagus	0.000811	0.0046	CcSEcCtD
Vemurafenib—Headache—Omeprazole—Barrett's esophagus	0.000811	0.0046	CcSEcCtD
Vemurafenib—RAF1—Endothelins—SLC9A1—Barrett's esophagus	0.000803	0.0168	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—CDKN2A—Barrett's esophagus	0.000786	0.0164	CbGpPWpGaD
Vemurafenib—BRAF—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000772	0.0161	CbGpPWpGaD
Vemurafenib—Nausea—Esomeprazole—Barrett's esophagus	0.000769	0.00436	CcSEcCtD
Vemurafenib—Nausea—Omeprazole—Barrett's esophagus	0.000769	0.00436	CcSEcCtD
Vemurafenib—CYP3A4—digestive system—Barrett's esophagus	0.000764	0.0265	CbGeAlD
Vemurafenib—CYP2D6—digestive system—Barrett's esophagus	0.000752	0.0261	CbGeAlD
Vemurafenib—ABCC1—S1P1 pathway—PTGS2—Barrett's esophagus	0.000746	0.0156	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—CXCL8—Barrett's esophagus	0.000713	0.0149	CbGpPWpGaD
Vemurafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000688	0.0144	CbGpPWpGaD
Vemurafenib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000687	0.0144	CbGpPWpGaD
Vemurafenib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000687	0.0144	CbGpPWpGaD
Vemurafenib—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000666	0.0139	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—ATP4A—Barrett's esophagus	0.000616	0.0129	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000583	0.0122	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000534	0.0112	CbGpPWpGaD
Vemurafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00053	0.0111	CbGpPWpGaD
Vemurafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00053	0.0111	CbGpPWpGaD
Vemurafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000515	0.0108	CbGpPWpGaD
Vemurafenib—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000508	0.0106	CbGpPWpGaD
Vemurafenib—BRAF—CDC42 signaling events—APC—Barrett's esophagus	0.000505	0.0105	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—TP53—Barrett's esophagus	0.000438	0.00915	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000436	0.00912	CbGpPWpGaD
Vemurafenib—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000431	0.009	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000423	0.00883	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000417	0.00872	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000411	0.00858	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000404	0.00843	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000396	0.00827	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000392	0.0082	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000382	0.00798	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000371	0.00775	CbGpPWpGaD
Vemurafenib—RAF1—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000369	0.00771	CbGpPWpGaD
Vemurafenib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000368	0.00768	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000361	0.00755	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000354	0.00739	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.000353	0.00738	CbGpPWpGaD
Vemurafenib—RAF1—CDC42 signaling events—APC—Barrett's esophagus	0.000349	0.0073	CbGpPWpGaD
Vemurafenib—ABCC1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000344	0.00719	CbGpPWpGaD
Vemurafenib—RAF1—IL-3 Signaling Pathway—CXCL8—Barrett's esophagus	0.000342	0.00715	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000337	0.00704	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—HGF—Barrett's esophagus	0.000332	0.00695	CbGpPWpGaD
Vemurafenib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000332	0.00694	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000317	0.00662	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000314	0.00656	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—HGF—Barrett's esophagus	0.000306	0.00639	CbGpPWpGaD
Vemurafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000305	0.00637	CbGpPWpGaD
Vemurafenib—BRAF—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000304	0.00635	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000299	0.00624	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000297	0.00621	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000296	0.00619	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.00029	0.00605	CbGpPWpGaD
Vemurafenib—RAF1—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000286	0.00598	CbGpPWpGaD
Vemurafenib—RAF1—BCR signaling pathway—RELA—Barrett's esophagus	0.000283	0.00591	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000276	0.00576	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000273	0.0057	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000269	0.00562	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000258	0.0054	CbGpPWpGaD
Vemurafenib—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000251	0.00525	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000251	0.00524	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.00025	0.00522	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000228	0.00475	CbGpPWpGaD
Vemurafenib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000226	0.00473	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000223	0.00466	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000222	0.00463	CbGpPWpGaD
Vemurafenib—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000221	0.00462	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000219	0.00458	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000219	0.00457	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000217	0.00453	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000214	0.00448	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000212	0.00444	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—HGF—Barrett's esophagus	0.000212	0.00442	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00021	0.00439	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000207	0.00432	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000205	0.00428	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000201	0.0042	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—APC—Barrett's esophagus	0.000196	0.0041	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000193	0.00403	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000191	0.00399	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000189	0.00395	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000188	0.00393	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000188	0.00392	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000187	0.00391	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000186	0.00389	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000185	0.00387	CbGpPWpGaD
Vemurafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000175	0.00365	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000167	0.0035	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000165	0.00345	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000156	0.00327	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000155	0.00324	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000154	0.00322	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—RELA—Barrett's esophagus	0.000153	0.0032	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000145	0.00303	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000144	0.003	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000143	0.00299	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.00014	0.00292	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000139	0.00291	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000139	0.00291	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000136	0.00284	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000133	0.00277	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000131	0.00274	CbGpPWpGaD
Vemurafenib—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000131	0.00273	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.00013	0.00272	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.00013	0.00272	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—RELA—Barrett's esophagus	0.000128	0.00267	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000123	0.00258	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000122	0.00256	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000119	0.00248	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000119	0.00248	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000115	0.00241	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000115	0.00239	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000114	0.00238	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GAST—Barrett's esophagus	0.000114	0.00237	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000113	0.00237	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGES—Barrett's esophagus	0.000112	0.00233	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SLC9A1—Barrett's esophagus	0.000106	0.00222	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000101	0.00211	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGES—Barrett's esophagus	9.82e-05	0.00205	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GAST—Barrett's esophagus	9.7e-05	0.00203	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—HGF—Barrett's esophagus	9.66e-05	0.00202	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.52e-05	0.00199	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	9.5e-05	0.00199	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	9e-05	0.00188	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—Barrett's esophagus	8.9e-05	0.00186	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—RELA—Barrett's esophagus	8.85e-05	0.00185	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CYP26A1—Barrett's esophagus	8.46e-05	0.00177	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—Barrett's esophagus	7.83e-05	0.00164	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—SST—Barrett's esophagus	7.78e-05	0.00163	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	7.44e-05	0.00156	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SLC9A1—Barrett's esophagus	7.35e-05	0.00154	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SLC9A1—Barrett's esophagus	7.28e-05	0.00152	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.07e-05	0.00148	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.07e-05	0.00148	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—PPARG—Barrett's esophagus	7.06e-05	0.00148	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GAST—Barrett's esophagus	6.71e-05	0.0014	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SST—Barrett's esophagus	6.65e-05	0.00139	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.25e-05	0.00131	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SLC9A1—Barrett's esophagus	6.1e-05	0.00127	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGES—Barrett's esophagus	6.06e-05	0.00127	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—RELA—Barrett's esophagus	5.72e-05	0.00119	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	5.37e-05	0.00112	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HGF—Barrett's esophagus	5.2e-05	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HGF—Barrett's esophagus	5.07e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—RELA—Barrett's esophagus	5.05e-05	0.00105	CbGpPWpGaD
Vemurafenib—BRAF—Disease—APC—Barrett's esophagus	5.02e-05	0.00105	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	5e-05	0.00105	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.92e-05	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—RELA—Barrett's esophagus	4.85e-05	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SST—Barrett's esophagus	4.6e-05	0.000961	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP26A1—Barrett's esophagus	4.59e-05	0.00096	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	4.24e-05	0.000886	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—Barrett's esophagus	3.81e-05	0.000797	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.79e-05	0.000793	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—APC—Barrett's esophagus	3.52e-05	0.000735	CbGpPWpGaD
Vemurafenib—RAF1—Disease—APC—Barrett's esophagus	3.47e-05	0.000726	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—APC—Barrett's esophagus	3.44e-05	0.00072	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.39e-05	0.000709	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SLC9A1—Barrett's esophagus	3.31e-05	0.000692	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.27e-05	0.000684	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—Barrett's esophagus	3.24e-05	0.000678	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	3.21e-05	0.000671	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—Barrett's esophagus	3.03e-05	0.000634	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—RELA—Barrett's esophagus	2.94e-05	0.000614	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARG—Barrett's esophagus	2.78e-05	0.000582	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RELA—Barrett's esophagus	2.75e-05	0.000574	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.73e-05	0.000571	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.67e-05	0.000558	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—Barrett's esophagus	2.64e-05	0.000551	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—Barrett's esophagus	2.61e-05	0.000546	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—Barrett's esophagus	2.59e-05	0.000541	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.48e-05	0.000518	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARG—Barrett's esophagus	2.45e-05	0.000512	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APC—Barrett's esophagus	2.43e-05	0.000508	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.37e-05	0.000496	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	2.32e-05	0.000484	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—Barrett's esophagus	2.19e-05	0.000458	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.93e-05	0.000403	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RELA—Barrett's esophagus	1.9e-05	0.000397	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.87e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—Barrett's esophagus	1.79e-05	0.000374	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.79e-05	0.000374	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—Barrett's esophagus	1.75e-05	0.000365	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—Barrett's esophagus	1.59e-05	0.000332	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—Barrett's esophagus	1.51e-05	0.000316	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.25e-05	0.000261	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—Barrett's esophagus	1.19e-05	0.000248	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—Barrett's esophagus	1.1e-05	0.00023	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	1.06e-05	0.000221	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	9.82e-06	0.000205	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	8.32e-06	0.000174	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	8.16e-06	0.000171	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.42e-06	0.000134	CbGpPWpGaD
